The New Bottleneck Isn’t Computing Power — It’s Just Power
Issued on behalf of LIXTE Biotechnology Holdings, Inc.…
7,210$
-5,26%
Echtzeit-Aktienkurs Lixte Biotechnology Holdings Inc.
Bid:
Ask:
Nachrichten zur Lixte Biotechnology Holdings Inc. Aktie
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering
New York, NY, July 09, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm,…
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by…